Stock Track | Tandem Diabetes Care Surges 5.34% After-Hours on Strong Q1 Sales Beat and Solid Guidance

Stock Track

May 01, 2025

Shares of Tandem Diabetes Care (NASDAQ:TNDM) soared 5.34% in after-hours trading on Wednesday following the release of its first-quarter earnings report, which showcased better-than-expected sales figures and reassuring forward guidance.

The medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.30% increase compared to the same period last year. Despite the strong top-line performance, Tandem's adjusted earnings per share came in at a loss of $(0.67), slightly missing the expected loss of $(0.61) per share.

Investors appeared to focus on the revenue beat and the company's forward-looking statements. Tandem Diabetes Care provided fiscal year 2025 revenue guidance of $997 million to $1.007 billion, aligning closely with the consensus estimate of $999 million. This outlook, combined with a reported gross margin of 51% for Q1, seems to have bolstered investor confidence in the company's growth trajectory and operational efficiency, driving the stock's after-hours rally.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1146129859"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146129859\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146129859?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-01 04:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146129859","market":"hk","top_or_hot":-1,"title":"Stock Track | Tandem Diabetes Care Surges 5.34% After-Hours on Strong Q1 Sales Beat and Solid Guidance","media":"Stock Track","content":"<p>Shares of Tandem Diabetes Care (NASDAQ:TNDM) soared 5.34% in after-hours trading on Wednesday following the release of its first-quarter earnings report, which showcased better-than-expected sales figures and reassuring forward guidance.</p>\n\n<p>The medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.30% increase compared to the same period last year. Despite the strong top-line performance, Tandem's adjusted earnings per share came in at a loss of $(0.67), slightly missing the expected loss of $(0.61) per share.</p>\n\n<p>Investors appeared to focus on the revenue beat and the company's forward-looking statements. Tandem Diabetes Care provided fiscal year 2025 revenue guidance of $997 million to $1.007 billion, aligning closely with the consensus estimate of $999 million. This outlook, combined with a reported gross margin of 51% for Q1, seems to have bolstered investor confidence in the company's growth trajectory and operational efficiency, driving the stock's after-hours rally.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tandem Diabetes Care Surges 5.34% After-Hours on Strong Q1 Sales Beat and Solid Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tandem Diabetes Care Surges 5.34% After-Hours on Strong Q1 Sales Beat and Solid Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-01 04:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Tandem Diabetes Care (NASDAQ:TNDM) soared 5.34% in after-hours trading on Wednesday following the release of its first-quarter earnings report, which showcased better-than-expected sales figures and reassuring forward guidance.</p>\n\n<p>The medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.30% increase compared to the same period last year. Despite the strong top-line performance, Tandem's adjusted earnings per share came in at a loss of $(0.67), slightly missing the expected loss of $(0.61) per share.</p>\n\n<p>Investors appeared to focus on the revenue beat and the company's forward-looking statements. Tandem Diabetes Care provided fiscal year 2025 revenue guidance of $997 million to $1.007 billion, aligning closely with the consensus estimate of $999 million. This outlook, combined with a reported gross margin of 51% for Q1, seems to have bolstered investor confidence in the company's growth trajectory and operational efficiency, driving the stock's after-hours rally.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNDM","symbol_name":"Tandem Diabetes","start_time":0,"source_url":"","article_id":"1146129859","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146129859","pubTimestamp":1746045154,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Tandem Diabetes Care  soared 5.34% in after-hours trading on Wednesday following the release of its first-quarter earnings report, which showcased better-than-expected sales figures and reassuring forward guidance.The medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.30% increase compared to the same period last year. Despite the ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNDM":"Tandem Diabetes"},"translate_title":"由于第一季度强劲的销售增长和可靠的指导，Tandem Diabetes Care盘后股价飙升5.34%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":1},"content_text":"Shares of Tandem Diabetes Care (NASDAQ:TNDM) soared 5.34% in after-hours trading on Wednesday following the release of its first-quarter earnings report, which showcased better-than-expected sales figures and reassuring forward guidance.\nThe medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.30% increase compared to the same period last year. Despite the strong top-line performance, Tandem's adjusted earnings per share came in at a loss of $(0.67), slightly missing the expected loss of $(0.61) per share.\nInvestors appeared to focus on the revenue beat and the company's forward-looking statements. Tandem Diabetes Care provided fiscal year 2025 revenue guidance of $997 million to $1.007 billion, aligning closely with the consensus estimate of $999 million. This outlook, combined with a reported gross margin of 51% for Q1, seems to have bolstered investor confidence in the company's growth trajectory and operational efficiency, driving the stock's after-hours rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}